WHO guideline on country pharmaceutical pricing policies

WHO guideline on country pharmaceutical pricing policies
Author:
Publisher: World Health Organization
Total Pages: 70
Release: 2020-09-29
Genre: Business & Economics
ISBN: 9240011870

In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.

Supporting Member States in reaching informed decision-making on engaging with private sector entities for the prevention and control of noncommunicable diseases

Supporting Member States in reaching informed decision-making on engaging with private sector entities for the prevention and control of noncommunicable diseases
Author: World Health Organization
Publisher: World Health Organization
Total Pages: 62
Release: 2024-07-13
Genre: Medical
ISBN: 9240094849

The Decision-making tool promotes a principles-based approach in engagements with private sector entities so that credibility, integrity and sound government processes are ensured and protected. It offers a systematic methodology for identifying opportunities where the private sector could contribute to strengthening national and subnational NCD responses, while safeguarding public health policies from undue influence and conflicts of interest. The tool was designed to be practical and applicable across diverse contexts and scenarios, and throughout the various phases of an engagement cycle (i.e. planning, implementation, monitoring and evaluation). The process consists of three phases, comprising a total of 10 steps that aim to guide users to reach informed decisions on engagement with private sector entities. Each step contains a set of questions presented in a sequential and comprehensive manner. It will help strengthening Member States’ capacity to engage with the private sector, by conducting due diligence of private sector actors, and identifying and mitigating risks, including conflict of interest and other risks associated with the engagement.

International Ethical Guidelines for Health-Related Research Involving Humans

International Ethical Guidelines for Health-Related Research Involving Humans
Author: Council for International Organizations of Medical Sciences (CIOMS)
Publisher: World Health Organization
Total Pages: 0
Release: 2017-01-31
Genre: Bioethics
ISBN: 9789290360889

"In the new 2016 version of the ethical guidelines, CIOMS provides answers to a number of pressing issues in research ethics. The Council does so by stressing the need for research having scientific and social value, by providing special guidelines for health-related research in low-resource settings, by detailing the provisions for involving vulnerable groups in research and for describing under what conditions biological samples and health-related data can be used for research."--Page 4 de la couverture.

Getting Health Reform Right

Getting Health Reform Right
Author: Marc Roberts
Publisher: Oxford University Press
Total Pages: 345
Release: 2008-04-23
Genre: Medical
ISBN: 0199888167

This book provides a multi-disciplinary framework for developing and analyzing health sector reforms, based on the authors' extensive international experience. It offers practical guidance - useful to policymakers, consultants, academics, and students alike - and stresses the need to take account of each country's economic, administrative, and political circumstances. The authors explain how to design effective government interventions in five areas - financing, payment, organization, regulation, and behavior - to improve the performance and equity of health systems around the world.

Reviewing Clinical Trials

Reviewing Clinical Trials
Author: Chinese University of Hong Kong
Publisher:
Total Pages: 153
Release: 2010
Genre: Clinical trials
ISBN: 9789881904119

The idea for this manual came from Pfizer in the US, which provided the Clinical Trials Centre at The University of Hong Kong, Hong Kong SAR, PR China with a nonbinding grant for its development. The general project layout protocol was accepted by Pfizer in July 2009. Pfizer has not in any way interfered with the project, except for providing nonbinding comments to the final product. The entire text of this manual was written by Johan PE Karlberg. Marjorie A Speers provided considerable and essential comments on the contents and the first and subsequent drafts. A group of international human research protection experts mostly working in non-profit institutions or organisations - see Contributors for details - reviewed and provided important comments on the contents and final draft. It was solely created with the intention to promote human research protection of participants in clinical trials. This manual will be translated into numerous languages and is provided free of charge as an electronic file over the Internet (http://www.ClinicalTrialMagnifier.com) and offered in print for a fee. The objective beyond this project is to establish educational activities, developed around the manual, and jointly organised with leading academic institutions worldwide.

Conflict of Interest in Medical Research, Education, and Practice

Conflict of Interest in Medical Research, Education, and Practice
Author: Institute of Medicine
Publisher: National Academies Press
Total Pages: 436
Release: 2009-09-16
Genre: Medical
ISBN: 0309145449

Collaborations of physicians and researchers with industry can provide valuable benefits to society, particularly in the translation of basic scientific discoveries to new therapies and products. Recent reports and news stories have, however, documented disturbing examples of relationships and practices that put at risk the integrity of medical research, the objectivity of professional education, the quality of patient care, the soundness of clinical practice guidelines, and the public's trust in medicine. Conflict of Interest in Medical Research, Education, and Practice provides a comprehensive look at conflict of interest in medicine. It offers principles to inform the design of policies to identify, limit, and manage conflicts of interest without damaging constructive collaboration with industry. It calls for both short-term actions and long-term commitments by institutions and individuals, including leaders of academic medical centers, professional societies, patient advocacy groups, government agencies, and drug, device, and pharmaceutical companies. Failure of the medical community to take convincing action on conflicts of interest invites additional legislative or regulatory measures that may be overly broad or unduly burdensome. Conflict of Interest in Medical Research, Education, and Practice makes several recommendations for strengthening conflict of interest policies and curbing relationships that create risks with little benefit. The book will serve as an invaluable resource for individuals and organizations committed to high ethical standards in all realms of medicine.

The Influence of the Pharmaceutical Industry

The Influence of the Pharmaceutical Industry
Author: Great Britain: Parliament: House of Commons: Health Committee
Publisher: The Stationery Office
Total Pages: 556
Release: 2005-04-26
Genre: Political Science
ISBN: 9780215024572

Incorporating HC 1030-i to iii.

A Practical Approach to Pharmaceutical Policy

A Practical Approach to Pharmaceutical Policy
Author: Andreas Seiter
Publisher: World Bank Publications
Total Pages: 240
Release: 2010-06-17
Genre: Medical
ISBN: 0821383876

This book offers policy makers a hands-on approach, tested in the World Bank’s field work in many countries, for developing policies that improve access to safe, effective medicines in health systems of low- and middle-income economies.